BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25356755)

  • 1. CD151-α3β1 integrin complexes suppress ovarian tumor growth by repressing slug-mediated EMT and canonical Wnt signaling.
    Baldwin LA; Hoff JT; Lefringhouse J; Zhang M; Jia C; Liu Z; Erfani S; Jin H; Xu M; She QB; van Nagell JR; Wang C; Chen L; Plattner R; Kaetzel DM; Luo J; Lu M; West D; Liu C; Ueland FR; Drapkin R; Zhou BP; Yang XH
    Oncotarget; 2014 Dec; 5(23):12203-17. PubMed ID: 25356755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of cathepsin B and uPAR inhibits CD151 and α3β1 integrin-mediated cell adhesion and invasion in glioma.
    Rao Malla R; Gopinath S; Alapati K; Gorantla B; Gondi CS; Rao JS
    Mol Carcinog; 2013 Oct; 52(10):777-90. PubMed ID: 22495828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD9/CD81 tetraspanin complex and tetraspanin CD151 regulate α3β1 integrin-dependent tumor cell behaviors by overlapping but distinct mechanisms.
    Gustafson-Wagner E; Stipp CS
    PLoS One; 2013; 8(4):e61834. PubMed ID: 23613949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.
    Zhou P; Erfani S; Liu Z; Jia C; Chen Y; Xu B; Deng X; Alfáro JE; Chen L; Napier D; Lu M; Huang JA; Liu C; Thibault O; Segal R; Zhou BP; Kyprianou N; Horbinski C; Yang XH
    Oncotarget; 2015 Oct; 6(30):29675-93. PubMed ID: 26377974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD151 represses mammary gland development by maintaining the niches of progenitor cells.
    Yin Y; Deng X; Liu Z; Baldwin LA; Lefringhouse J; Zhang J; Hoff JT; Erfani SF; Rucker EB; O'Connor K; Liu C; Wu Y; Zhou BP; Yang XH
    Cell Cycle; 2014; 13(17):2707-22. PubMed ID: 25486358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
    Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
    Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD151 and integrin α3β1 contribute to the stabilization of integrin α6β4-containing cell-matrix adhesions.
    Te Molder L; Juksar J; Harkes R; Wang W; Kreft M; Sonnenberg A
    J Cell Sci; 2019 Oct; 132(19):. PubMed ID: 31488507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer.
    Zhu J; Cai T; Zhou J; Du W; Zeng Y; Liu T; Fu Y; Li Y; Qian Q; Yang XH; Li Q; Huang JA; Liu Z
    J Exp Clin Cancer Res; 2021 Jun; 40(1):192. PubMed ID: 34108040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD151 promotes α3β1 integrin-dependent organization of carcinoma cell junctions and restrains collective cell invasion.
    Zevian SC; Johnson JL; Winterwood NE; Walters KS; Herndon ME; Henry MD; Stipp CS
    Cancer Biol Ther; 2015; 16(11):1626-40. PubMed ID: 26418968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical role for tetraspanin CD151 in alpha3beta1 and alpha6beta4 integrin-dependent tumor cell functions on laminin-5.
    Winterwood NE; Varzavand A; Meland MN; Ashman LK; Stipp CS
    Mol Biol Cell; 2006 Jun; 17(6):2707-21. PubMed ID: 16571677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
    Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
    J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAM-A interacts with α3β1 integrin and tetraspanins CD151 and CD9 to regulate collective cell migration of polarized epithelial cells.
    Thölmann S; Seebach J; Otani T; Florin L; Schnittler H; Gerke V; Furuse M; Ebnet K
    Cell Mol Life Sci; 2022 Jan; 79(2):88. PubMed ID: 35067832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.
    Baldwin G; Novitskaya V; Sadej R; Pochec E; Litynska A; Hartmann C; Williams J; Ashman L; Eble JA; Berditchevski F
    J Biol Chem; 2008 Dec; 283(51):35445-54. PubMed ID: 18852263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.
    Medrano M; Communal L; Brown KR; Iwanicki M; Normand J; Paterson J; Sircoulomb F; Krzyzanowski P; Novak M; Doodnauth SA; Saiz FS; Cullis J; Al-Awar R; Neel BG; McPherson J; Drapkin R; Ailles L; Mes-Massons AM; Rottapel R
    Cell Rep; 2017 Mar; 18(10):2343-2358. PubMed ID: 28273451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tetraspanin CD151 regulates cell morphology and intracellular signaling on laminin-511.
    Yamada M; Sumida Y; Fujibayashi A; Fukaguchi K; Sanzen N; Nishiuchi R; Sekiguchi K
    FEBS J; 2008 Jul; 275(13):3335-51. PubMed ID: 18492066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of tetraspanin CD151 alters the Wnt oncogene-induced mammary tumorigenesis: A cell type-linked function and signaling.
    Li H; Li J; Han R; Deng X; Shi J; Huang H; Hamad N; McCaughley A; Liu J; Wang C; Chen K; Wei D; Qiang J; Thatcher S; Wu Y; Liu C; Thibault O; Wei X; Chen S; Qian H; Zhou BP; Xu P; Yang XH
    Neoplasia; 2019 Dec; 21(12):1151-1163. PubMed ID: 31783316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α3β1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments.
    Scales TM; Jayo A; Obara B; Holt MR; Hotchin NA; Berditchevski F; Parsons M
    Oncogene; 2013 Aug; 32(34):3965-79. PubMed ID: 22986527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
    Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
    Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition.
    Gasior K; Hauck M; Wilson A; Bhattacharya S
    Theor Biol Med Model; 2017 Oct; 14(1):19. PubMed ID: 28992816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.